116 related articles for article (PubMed ID: 19211984)
1. Increased synphilin-1 expression in human elderly brains with substantia nigra Marinesco bodies.
Krygowska-Wajs A; Lenda T; Adamek D; Moskała M; Kuter K; Kunz J; Smiałowska M; Ossowska K
Pharmacol Rep; 2008; 60(6):914-24. PubMed ID: 19211984
[TBL] [Abstract][Full Text] [Related]
2. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
3. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
[TBL] [Abstract][Full Text] [Related]
4. Parallel enlargement of Marinesco bodies and nuclei and progressive deposition of p62 in pigmented neurons of the substantia nigra.
Amano R; Toru S; Yamane M; Kitagawa M; Hirokawa K; Uchihara T
Neuropathology; 2020 Aug; 40(4):328-335. PubMed ID: 32202001
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
6. Marinesco bodies and substantia nigra neuron density in Parkinson's disease.
Abbott RD; Nelson JS; Ross GW; Uyehara-Lock JH; Tanner CM; Masaki KH; Launer LJ; White LR; Petrovitch H
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):621-630. PubMed ID: 28626918
[TBL] [Abstract][Full Text] [Related]
7. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
8. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
9. Synphilin in normal human brains and in synucleinopathies: studies with new antibodies.
Murray IJ; Medford MA; Guan HP; Rueter SM; Trojanowski JQ; Lee VM
Acta Neuropathol; 2003 Feb; 105(2):177-84. PubMed ID: 12536229
[TBL] [Abstract][Full Text] [Related]
10. [DISTRIBUTION OF THE MARINESCO BODIES IN THE NEURONS OF HUMAN BRAIN SUBSTANTIA NIGRA].
Grigoriyev IP; Gusel'nikova VV; Sukhorukova YG; Korzhevskiy DE
Morfologiia; 2015; 148(5):28-31. PubMed ID: 26987214
[TBL] [Abstract][Full Text] [Related]
11. Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.
Ito T; Niwa J; Hishikawa N; Ishigaki S; Doyu M; Sobue G
J Biol Chem; 2003 Aug; 278(31):29106-14. PubMed ID: 12750386
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein.
Woulfe J; Gray D; Prichett-Pejic W; Munoz DG; Chretien M
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1200-7. PubMed ID: 15581187
[TBL] [Abstract][Full Text] [Related]
13. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
[TBL] [Abstract][Full Text] [Related]
14. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation.
Szargel R; Rott R; Engelender S
Cell Mol Life Sci; 2008 Jan; 65(1):80-8. PubMed ID: 17982729
[TBL] [Abstract][Full Text] [Related]
15. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
Matsuoka Y; Vila M; Lincoln S; McCormack A; Picciano M; LaFrancois J; Yu X; Dickson D; Langston WJ; McGowan E; Farrer M; Hardy J; Duff K; Przedborski S; Di Monte DA
Neurobiol Dis; 2001 Jun; 8(3):535-9. PubMed ID: 11442360
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
17. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
Iseki E; Kato M; Marui W; Uéda K; Kosaka K
J Neurol Sci; 2001 Apr; 185(2):129-34. PubMed ID: 11311294
[TBL] [Abstract][Full Text] [Related]
18. Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.
Bandopadhyay R; Kingsbury AE; Muqit MM; Harvey K; Reid AR; Kilford L; Engelender S; Schlossmacher MG; Wood NW; Latchman DS; Harvey RJ; Lees AJ
Neurobiol Dis; 2005 Nov; 20(2):401-11. PubMed ID: 15894486
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
20. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease.
Hishikawa N; Hashizume Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2001 Oct; 27(5):362-72. PubMed ID: 11679088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
